TAIDOC TECHNOLOGY CORP
TaiDoc Technology Corporation manufactures and markets medical devices in Taiwan and internationally. The company offers In vitro diagnostics products, including multiple parameter monitoring systems, point of care testing devices, and lancet and lancing devices; vet health care products comprise blood glucose and calcium meters, and blood ketone meters; and medical devices, such as nebulizers, t… Read more
TAIDOC TECHNOLOGY CORP (4736) - Net Assets
Latest net assets as of September 2025: NT$9.73 Billion TWD
Based on the latest financial reports, TAIDOC TECHNOLOGY CORP (4736) has net assets worth NT$9.73 Billion TWD as of September 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (NT$12.79 Billion) and total liabilities (NT$3.06 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | NT$9.73 Billion |
| % of Total Assets | 76.09% |
| Annual Growth Rate | 12.17% |
| 5-Year Change | 43.83% |
| 10-Year Change | 226.82% |
| Growth Volatility | 15.5 |
TAIDOC TECHNOLOGY CORP - Net Assets Trend (2009–2024)
This chart illustrates how TAIDOC TECHNOLOGY CORP's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for TAIDOC TECHNOLOGY CORP (2009–2024)
The table below shows the annual net assets of TAIDOC TECHNOLOGY CORP from 2009 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-09-30 | NT$9.52 Billion | +2.85% |
| 2023-09-30 | NT$9.26 Billion | -7.36% |
| 2022-09-30 | NT$9.99 Billion | +30.92% |
| 2021-09-30 | NT$7.63 Billion | +15.31% |
| 2020-09-30 | NT$6.62 Billion | +46.77% |
| 2019-09-30 | NT$4.51 Billion | +12.13% |
| 2018-09-30 | NT$4.02 Billion | +26.55% |
| 2017-09-30 | NT$3.18 Billion | +3.36% |
| 2016-09-30 | NT$3.08 Billion | +5.56% |
| 2015-09-30 | NT$2.91 Billion | +17.06% |
| 2014-09-30 | NT$2.49 Billion | +17.79% |
| 2013-09-30 | NT$2.11 Billion | +7.83% |
| 2012-09-30 | NT$1.96 Billion | -4.62% |
| 2011-09-30 | NT$2.05 Billion | -9.36% |
| 2010-09-30 | NT$2.27 Billion | +33.25% |
| 2009-09-30 | NT$1.70 Billion | -- |
Equity Component Analysis
This analysis shows how different components contribute to TAIDOC TECHNOLOGY CORP's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 768.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (September 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | NT$4.84 Billion | 53.32% |
| Common Stock | NT$953.74 Million | 10.50% |
| Other Components | NT$3.29 Billion | 36.18% |
| Total Equity | NT$9.09 Billion | 100.00% |
TAIDOC TECHNOLOGY CORP Competitors by Market Cap
The table below lists competitors of TAIDOC TECHNOLOGY CORP ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
InfoVision Optoelectronics Kunshan Co Ltd
SHG:688055
|
$206.50 Million |
|
Qingdao Victall Railway Co Ltd
SHG:605001
|
$206.58 Million |
|
Wuhu Conch Profiles and Science Co Ltd
SHE:000619
|
$206.70 Million |
|
Anhui Jinchun Nonwoven Co Ltd
SHE:300877
|
$206.70 Million |
|
OVH GROUPE (PROM.)EO 1
F:7U7
|
$206.34 Million |
|
Shenzhen Asiantime International Construction Co Ltd
SHE:002811
|
$206.24 Million |
|
Donga Socio Holdings
KO:000640
|
$206.15 Million |
|
Youngtek Electronics
TWO:6261
|
$206.07 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in TAIDOC TECHNOLOGY CORP's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 8,900,903,000 to 9,085,827,000, a change of 184,924,000 (2.1%).
- Net income of 1,158,768,000 contributed positively to equity growth.
- Dividend payments of 953,744,000 reduced retained earnings.
- Other comprehensive income increased equity by 43,016,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | NT$1.16 Billion | +12.75% |
| Dividends Paid | NT$953.74 Million | -10.5% |
| Other Comprehensive Income | NT$43.02 Million | +0.47% |
| Other Changes | NT$-63.12 Million | -0.69% |
| Total Change | NT$- | 2.08% |
Book Value vs Market Value Analysis
This analysis compares TAIDOC TECHNOLOGY CORP's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.34x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 4.84x to 1.34x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2009-09-30 | NT$26.22 | NT$127.00 | x |
| 2010-09-30 | NT$33.20 | NT$127.00 | x |
| 2011-09-30 | NT$27.20 | NT$127.00 | x |
| 2012-09-30 | NT$26.50 | NT$127.00 | x |
| 2013-09-30 | NT$27.76 | NT$127.00 | x |
| 2014-09-30 | NT$30.60 | NT$127.00 | x |
| 2015-09-30 | NT$34.48 | NT$127.00 | x |
| 2016-09-30 | NT$35.95 | NT$127.00 | x |
| 2017-09-30 | NT$36.49 | NT$127.00 | x |
| 2018-09-30 | NT$46.34 | NT$127.00 | x |
| 2019-09-30 | NT$49.75 | NT$127.00 | x |
| 2020-09-30 | NT$68.96 | NT$127.00 | x |
| 2021-09-30 | NT$77.08 | NT$127.00 | x |
| 2022-09-30 | NT$100.30 | NT$127.00 | x |
| 2023-09-30 | NT$92.95 | NT$127.00 | x |
| 2024-09-30 | NT$94.90 | NT$127.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently TAIDOC TECHNOLOGY CORP utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 12.75%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 24.97%
- • Asset Turnover: 0.38x
- • Equity Multiplier: 1.35x
- Recent ROE (12.75%) is below the historical average (17.72%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2009 | 25.58% | 18.91% | 0.80x | 1.70x | NT$243.75 Million |
| 2010 | 9.79% | 9.90% | 0.68x | 1.44x | NT$-4.41 Million |
| 2011 | 11.16% | 10.64% | 0.67x | 1.56x | NT$22.51 Million |
| 2012 | 8.71% | 6.69% | 0.79x | 1.65x | NT$-23.99 Million |
| 2013 | 17.01% | 14.87% | 0.72x | 1.58x | NT$141.25 Million |
| 2014 | 17.75% | 16.96% | 0.64x | 1.64x | NT$186.78 Million |
| 2015 | 15.71% | 16.88% | 0.61x | 1.53x | NT$161.83 Million |
| 2016 | 16.44% | 15.54% | 0.62x | 1.70x | NT$191.66 Million |
| 2017 | 13.93% | 12.71% | 0.55x | 1.99x | NT$119.97 Million |
| 2018 | 22.62% | 20.17% | 0.58x | 1.94x | NT$489.10 Million |
| 2019 | 15.20% | 16.04% | 0.53x | 1.79x | NT$226.98 Million |
| 2020 | 23.67% | 25.77% | 0.64x | 1.43x | NT$878.69 Million |
| 2021 | 26.72% | 30.42% | 0.62x | 1.42x | NT$1.24 Billion |
| 2022 | 34.99% | 35.14% | 0.75x | 1.33x | NT$2.42 Billion |
| 2023 | 11.43% | 21.17% | 0.40x | 1.34x | NT$127.28 Million |
| 2024 | 12.75% | 24.97% | 0.38x | 1.35x | NT$250.19 Million |
Industry Comparison
This section compares TAIDOC TECHNOLOGY CORP's net assets metrics with peer companies in the Medical Devices industry.
Industry Context
- Industry: Medical Devices
- Average net assets among peers: $1,188,209,400
- Average return on equity (ROE) among peers: 10.09%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| TAIDOC TECHNOLOGY CORP (4736) | NT$9.73 Billion | 25.58% | 0.31x | $206.41 Million |
| Health & Life Co., Ltd. (1781) | $393.05 Million | 6.17% | 1.08x | $12.92 Million |
| Hi-Clearance (1788) | $3.00 Billion | 11.98% | 0.65x | $104.25 Million |
| Radiant Innovation (3373) | $865.89 Million | -3.30% | 0.08x | $18.76 Million |
| Wellell Inc (4106) | $458.47 Million | 22.17% | 0.32x | $37.12 Million |
| Rossmax International Ltd (4121) | $1.66 Billion | 8.16% | 1.02x | $34.41 Million |
| United Orthopedic (4129) | $2.22 Billion | 5.87% | 0.94x | $279.97 Million |
| Dynamic Medical Technologies (4138) | $1.70 Billion | 12.34% | 0.81x | $39.16 Million |
| Ok Biotech Co Ltd (4155) | $452.10 Million | 21.38% | 0.72x | $44.61 Million |
| Bioptik Technology (4161) | $824.15 Million | 10.40% | 0.82x | $30.48 Million |
| EPS Bio Technology Corp. (4183) | $304.55 Million | 5.68% | 0.78x | $4.27 Million |